F. Trémollières

485 total citations
22 papers, 372 citations indexed

About

F. Trémollières is a scholar working on Genetics, Orthopedics and Sports Medicine and Oncology. According to data from OpenAlex, F. Trémollières has authored 22 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 11 papers in Orthopedics and Sports Medicine and 6 papers in Oncology. Recurrent topics in F. Trémollières's work include Bone health and osteoporosis research (11 papers), Estrogen and related hormone effects (10 papers) and Menopause: Health Impacts and Treatments (4 papers). F. Trémollières is often cited by papers focused on Bone health and osteoporosis research (11 papers), Estrogen and related hormone effects (10 papers) and Menopause: Health Impacts and Treatments (4 papers). F. Trémollières collaborates with scholars based in France, Australia and United Kingdom. F. Trémollières's co-authors include C Ribot, J. M. Pouillès, J. Louvet, Roland Peyron, Michel Bonneu, S. Brun, E Caussé, Elaine Dennison, Nasser M. Al‐Daghri and P. Collard and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Drugs and Osteoporosis International.

In The Last Decade

F. Trémollières

19 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Trémollières France 9 204 100 80 75 75 22 372
O.M. Hauache Brazil 10 79 0.4× 53 0.5× 42 0.5× 30 0.4× 62 0.8× 12 341
Juraj Payer Slovakia 12 60 0.3× 99 1.0× 40 0.5× 180 2.4× 57 0.8× 56 384
Kerstin Stähr Germany 10 152 0.7× 120 1.2× 102 1.3× 145 1.9× 33 0.4× 28 442
Christos Zois Greece 6 120 0.6× 85 0.8× 52 0.7× 197 2.6× 17 0.2× 8 471
Charalampos Tsentidis Greece 12 63 0.3× 97 1.0× 59 0.7× 77 1.0× 49 0.7× 26 371
Paul Taelman Belgium 7 94 0.5× 133 1.3× 71 0.9× 532 7.1× 115 1.5× 8 636
Dominique Thibaud France 12 114 0.6× 112 1.1× 255 3.2× 44 0.6× 76 1.0× 22 609
Pedro Henrique Silveira Corrêa Brazil 9 99 0.5× 110 1.1× 92 1.1× 84 1.1× 14 0.2× 20 301
Carlos García Gómez Spain 9 226 1.1× 59 0.6× 101 1.3× 22 0.3× 23 0.3× 27 330
İbrahim Gülhan Türkiye 12 19 0.1× 42 0.4× 47 0.6× 47 0.6× 79 1.1× 26 349

Countries citing papers authored by F. Trémollières

Since Specialization
Citations

This map shows the geographic impact of F. Trémollières's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Trémollières with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Trémollières more than expected).

Fields of papers citing papers by F. Trémollières

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Trémollières. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Trémollières. The network helps show where F. Trémollières may publish in the future.

Co-authorship network of co-authors of F. Trémollières

This figure shows the co-authorship network connecting the top 25 collaborators of F. Trémollières. A scholar is included among the top collaborators of F. Trémollières based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Trémollières. F. Trémollières is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weyl, Ariane, et al.. (2023). Femmes à très haut risque de cancer du sein : contraception, traitement hormonal substitutif et dépistage personnalisé. Gynécologie Obstétrique Fertilité & Sénologie . 51(5). 275–283. 1 indexed citations
2.
Trémollières, F., Nathalie Chabbert‐Buffet, Geneviève Plu‐Bureau, et al.. (2021). Les femmes ménopausées : recommandations pour la pratique clinique du CNGOF et du GEMVi (Texte court). Gynécologie Obstétrique Fertilité & Sénologie . 49(5). 305–317.
3.
Trémollières, F., et al.. (2021). Ménopause, traitement hormonal de ménopause et ostéoporose. RPC Les femmes ménopausées du CNGOF et du GEMVi. Gynécologie Obstétrique Fertilité & Sénologie . 49(5). 420–437. 2 indexed citations
4.
Fuggle, Nicholas R., Cyrus Cooper, Nicholas C. Harvey, et al.. (2020). Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs. Drugs. 80(15). 1537–1552. 43 indexed citations
5.
Trémollières, F.. (2010). Tissu conjonctif de soutien et genèse des prolapsus. Gynécologie Obstétrique & Fertilité. 38(6). 388–393. 8 indexed citations
6.
Ribot, C & F. Trémollières. (2007). Traitement hormonal chez les femmes ménopausées: tous les traitements sont-ils équivalents?. Gynécologie Obstétrique & Fertilité. 35(5). 388–397. 8 indexed citations
7.
Pouillès, J. M., P. Collard, F. Trémollières, et al.. (2000). Accuracy and Precision of In Vivo Bone Mineral Measurements in Sheep Using Dual-Energy X-ray Absorptiometry. Calcified Tissue International. 66(1). 70–73. 19 indexed citations
8.
Ribot, C, et al.. (1995). [Hormone replacement therapy and early and late prevention of postmenopausal osteoporosis].. PubMed. 24(21). 999–1002. 1 indexed citations
9.
Ribot, C & F. Trémollières. (1995). [Sex steroids and bone tissue].. PubMed. 56(1). 49–55. 4 indexed citations
10.
Trémollières, F., et al.. (1995). [Anti-estrogens and bone tissue].. PubMed. 56(6). 603–8. 1 indexed citations
11.
Trémollières, F., J. M. Pouillès, & C Ribot. (1993). Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women.. The Journal of Clinical Endocrinology & Metabolism. 77(3). 683–686. 181 indexed citations
12.
Pouillès, J. M., et al.. (1992). 92104231 Assessment of the risk of post-menopausal osteoporosis using clinical factors. Maturitas. 15(2). 165–166. 4 indexed citations
13.
Ribot, C, F. Trémollières, & J. M. Pouillès. (1992). Effect of 17β-oestradiol and norethisterone acetate on vertebral bone mass and lipid metabolism in early postmenopausal women. Maturitas. 15(3). 217–223. 6 indexed citations
14.
Ribot, C, et al.. (1992). [Vertebral, femoral and radial bone density in simulation of prolonged weightlessness. Experience with healthy volunteers].. PubMed. 21(4). 160–4. 2 indexed citations
15.
Pouillès, J. M., et al.. (1991). 91139236 Risk factors of vertebral osteoporosis. Results of a study of 2279 women referred to a menopause clinic. Maturitas. 14(1). 77–77. 5 indexed citations
16.
Pouillès, J. M., F. Trémollières, E Caussé, J. Louvet, & C Ribot. (1991). Fluoride therapy in postmenopausal osteopenic women: Effect on vertebral and femoral bone density and prediction of bone response. Osteoporosis International. 1(2). 103–109. 19 indexed citations
17.
Pouillès, J. M., C Ribot, F. Trémollières, Michel Bonneu, & S. Brun. (1991). [Risk factors of vertebral osteoporosis. Results of a study of 2279 women referred to a menopause clinic].. PubMed. 58(3). 169–77. 13 indexed citations
18.
Pouillès, J. M., F. Trémollières, & C Ribot. (1990). [Performance of X-ray absorptiometry in post-menopausal vertebral osteoporosis. Discriminant value of vertebral and femoral measurements, fracture threshold, reproducibility].. PubMed. 57(12). 873–80. 1 indexed citations
19.
Ribot, C, F. Trémollières, J. M. Pouillès, J. Louvet, & Roland Peyron. (1989). Preventive effects of transdermal administration of 17|3-estradiol on postmenopausal bone loss: A 2-year prospective study. Gynecological Endocrinology. 3(4). 259–267. 37 indexed citations
20.
Trémollières, F., J. M. Pouillès, J. Louvet, & C Ribot. (1989). Bone and thyroid hormones. Clinical Rheumatology. 8(S2). 116–118. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026